This Technique for Studying Cell Receptors Could Have Sweeping Implications for Drug Development
August 28, 2024
August 28, 2024
NEW YORK, Aug. 28 (TNSres) -- Rockefeller University issued the following news:
One in every three FDA-approved drugs targets a single superfamily of receptors dotting the surfaces of human cells. From beta blockers to antihistamines, these essential, life-saving medications trigger winding biochemical pathways, via these receptors, to ultimately prevent a heart attack, or stop an allergic reaction in its tracks.
But scientists have learned that their story is much more . . .
One in every three FDA-approved drugs targets a single superfamily of receptors dotting the surfaces of human cells. From beta blockers to antihistamines, these essential, life-saving medications trigger winding biochemical pathways, via these receptors, to ultimately prevent a heart attack, or stop an allergic reaction in its tracks.
But scientists have learned that their story is much more . . .